These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34683845)

  • 1. Discovery and Validation of a Compound to Target Ewing's Sarcoma.
    Esfandiari Nazzaro E; Sabei FY; Vogel WK; Nazari M; Nicholson KS; Gafken PR; Taratula O; Taratula O; Davare MA; Leid M
    Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PARP inhibitor combinations with high-dose vitamin C in the treatment of Ewing sarcoma: two case reports and mechanistic overview.
    Adibi A; Tokat ÜM; Özgü E; Aydın E; Demiray İ; Demiray M
    Ther Adv Med Oncol; 2023; 15():17588359231213841. PubMed ID: 38107827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated chemical biology approach identifies specific vulnerability of Ewing's sarcoma to combined inhibition of Aurora kinases A and B.
    Winter GE; Rix U; Lissat A; Stukalov A; Müllner MK; Bennett KL; Colinge J; Nijman SM; Kubicek S; Kovar H; Kontny U; Superti-Furga G
    Mol Cancer Ther; 2011 Oct; 10(10):1846-56. PubMed ID: 21768330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
    Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
    J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A targeted combinatorial therapy for Ewing's sarcoma.
    Sabei FY; Taratula O; Albarqi HA; Al-Fatease AM; Moses AS; Demessie AA; Park Y; Vogel WK; Esfandiari Nazzaro E; Davare MA; Alani A; Leid M; Taratula O
    Nanomedicine; 2021 Oct; 37():102446. PubMed ID: 34303840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
    Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
    Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma.
    Werner S; Mendoza A; Hilger RA; Erlacher M; Reichardt W; Lissat A; Konanz C; Uhl M; Niemeyer CM; Khanna C; Kontny U
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):19-31. PubMed ID: 17823799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma.
    Arora S; Gonzales IM; Hagelstrom RT; Beaudry C; Choudhary A; Sima C; Tibes R; Mousses S; Azorsa DO
    Mol Cancer; 2010 Aug; 9():218. PubMed ID: 20718987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ewing's Sarcoma of the Breast in a Young Woman: A Case Report and Review of the Literature.
    Papi S; Combi F; Segattini S; Accogli S; Palma E; Gambini A; Andreotti A; Luppi G; Tazzioli G
    Front Oncol; 2022; 12():915844. PubMed ID: 35903703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of Ewing's sarcoma.
    Iwamoto Y
    Jpn J Clin Oncol; 2007 Feb; 37(2):79-89. PubMed ID: 17272319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
    Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
    Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extra skeletal Soft Tissue Ewing's Sarcoma with Variant Translocation of Chromosome t (4; 22) (q35; q12)-A Case Report.
    Nagaraj P; H SC; Rao R; Manohar S
    J Orthop Case Rep; 2013; 3(4):12-5. PubMed ID: 27298923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Status of Proteomics in Ewing's Sarcoma.
    Kondo T
    Proteomics Clin Appl; 2019 May; 13(3):e1700130. PubMed ID: 29992772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is There a Predisposition Gene for Ewing's Sarcoma?
    Randall RL; Lessnick SL; Jones KB; Gouw LG; Cummings JE; Cannon-Albright L; Schiffman JD
    J Oncol; 2010; 2010():397632. PubMed ID: 20300555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinonasal FUS-ERG-Rearranged Ewing's Sarcoma Mimicking Glomangiopericytoma.
    Zhou M; Ko YCK; Charville GW; Ganjoo KN
    Case Rep Oncol; 2020; 13(3):1393-1396. PubMed ID: 33442361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted therapies in Ewing's sarcoma.
    Scotlandi K
    Adv Exp Med Biol; 2006; 587():13-22. PubMed ID: 17163152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of EWS-ETS fusions in NIH3T3 cells reveals significant differences to Ewing's sarcoma.
    Braunreiter CL; Hancock JD; Coffin CM; Boucher KM; Lessnick SL
    Cell Cycle; 2006 Dec; 5(23):2753-9. PubMed ID: 17172842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity.
    Merchant MS; Woo CW; Mackall CL; Thiele CJ
    J Natl Cancer Inst; 2002 Nov; 94(22):1673-9. PubMed ID: 12441322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing's sarcoma cells.
    Kerschner-Morales SL; Kühne M; Becker S; Beck JF; Sonnemann J
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):2871-2883. PubMed ID: 32770382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Status and Perspectives of Patient-Derived Models for Ewing's Sarcoma.
    Kondo T
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32899796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.